Supplementation with the reduced form of Coenzyme Q10 decelerates phenotypic characteristics of senescence and induces a peroxisome proliferator-activated receptor-α gene expression signature in SAMP1 mice

Molecular Nutrition and Food Research

Volumn 54, Issue 6, 2010, Pages 805-815

  Schmelzer, Constance ^a   Kubo, Hiroshi ^b   Mori, Masayuki ^c   Sawashita, Jinko ^c   Kitano, Mitsuaki ^b   Hosoe, Kazunori ^b   Boomgaarden, Inka ^a   Döring, Frank ^a   Higuchi, Keiichi ^c  

^a UNIVERSITY OF KIEL   (Germany)

^b KANEKA CORPORATION   (Japan)

^c SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CoQ10; Gene expression; Inflammation; Lipid metabolism; Peroxisome proliferator activated receptor

Indexed keywords

DRUG DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UBIDECARENONE; UBIQUINONE;

AGING; ANIMAL; ARTICLE; DIET SUPPLEMENTATION; DRUG EFFECT; EATING; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; PHENOTYPE;

AGING; ANIMALS; DIETARY SUPPLEMENTS; EATING; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIVER; MICE; OXIDATION-REDUCTION; PHENOTYPE; PPAR ALPHA; UBIQUINONE;

MUS;

EID: 77954171665     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200900155     Document Type: Article

References (54)

1. Schmelzer, C., Lorenz, G., Lindner, I., Rimbach, G. et al., Effects of Coenzyme Q10 on TNF-alpha secretion in human and murine monocytic cell lines. Biofactors 2007, 31, 35-41.
2. Schmelzer, C., Lorenz, G., Rimbach, G., Doring, F., Influence of Coenzyme Q10 on release of pro-inflammatory chemo-kines in the human monocytic cell line THP-1. Biofactors 2007, 31, 211-217.
3. Groneberg, D. A., Kindermann, B., Althammer, M., Klapper, M. et al., Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2cells. Int. J. Biochem. Cell Biol. 2005, 37, 1208-1218.
4. Schmelzer, C., Lorenz, G., Rimbach, G., Doring, F., In vitro effects of the reduced form of coenzyme Q(10) on secretion levels of TNF-alpha and chemokines in response to LPS in the human monocytic cell line THP-1. J. Clin. Biochem. Nutr. 2009, 44, 62-66.
5. Schmelzer, C., Kitano, M., Rimbach, G., Niklowitz, P. et al., Effects of ubiquinol-10 on microRNA-146a expression in vitro and in vivo. Mediators Inflamm. 2009, 2009, 415437.
6. Takeda, T., Hosokawa, M., Higuchi, K., Hosono, M. et al., Anovel murine model of aging, senescence-accelerated mouse (SAM). Arch. Gerontol. Geriatr. 1994, 19, 185-192.
7. Takeda, T., Hosokawa, M., Higuchi, K., Senescence-accel-erated mouse (SAM): anovel murine model of senescence. Exp. Gerontol. 1997, 32, 105-109.
8. Takeda, T., Hosokawa, M., Takeshita, S., Irino, M. et al., Anew murine model of accelerated senescence. Mech. Ageing Dev. 1981, 17, 183-194.
9. Hosokawa, M., Kasai, R., Higuchi, K., Takeshita, S. et al., Grading score system: amethod for evaluation of the degree of senescence in senescence accelerated mouse (SAM). Mech. Ageing Dev. 1984, 26, 91-102.
10. Hosokawa, M., Ahigher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice. Mech. Ageing Dev. 2002, 123, 1553-1561.
11. Chiba, Y., Shimada, A., Kumagai, N., Yoshikawa, K. et al., The senescence-accelerated mouse (SAM): ahigher oxidative stress and age-dependent degenerative diseases model. Neurochem. Res. 2008, 34, 679-687.
12. Yamashita, S., Yamamoto, Y., Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal. Biochem. 1997, 250, 66-73.
13. Scherf, M., Epple, A., Werner, T., The next generation of literature analysis: integration of genomic analysis into text mining. Brief Bioinform. 2005, 6, 287-297.
14. Yan, J., Fujii, K., Yao, J., Kishida, H. et al., Reduced coen-zyme Q10 supplementation decelerates senescence in SAMP1 mice. Exp. Gerontol. 2006, 41, 130-140.
15. Galinier, A., Carriere, A., Fernandez, Y., Bessac, A. M. et al., Biological validation of coenzyme Q redox state by HPLC-EC measurement: relationship between coenzyme Q redox state and coenzyme Q content in rat tissues. FEBS Lett. 2004, 578, 53-57.
16. Navarro, F., Villalba, J. M., Crane, F. L., Mackellar, W. C., Navas, P., Aphospholipid-dependent NADH-coenzyme Q reductase from liver plasma membrane. Biochem. Biophys. Res. Commun. 1995, 212, 138-143.
17. Navarro, F., Navas, P., Burgess, J. R., Bello, R. I. et al., Vitamin E and selenium deficiency induces expression of the ubiquinone-dependent antioxidant system at the plasma membrane. Faseb J. 1998, 12, 1665-1673.
18. Vasiliou, V., Ross, D., Nebert, D. W., Update of the NAD(P)H: Quinone oxidoreductase (NQO) gene family. Hum. Genomics 2006, 2, 329-335.
19. Novo, E., Parola, M., Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2008, 1, 5.
20. Merlo Pich, M., Castagnoli, A., Biondi, A., Bernacchia, A. et al., Ubiquinol and a coenzyme Q reducing system protect platelet mitochondrial function of transfusional buffy coats from oxidative stress. Free Radic. Res. 2002, 36, 429-436.
21. Bello, R. I., Gomez-Diaz, C., Buron, M. I., Alcain, F. J. et al., Enhanced anti-oxidant protection of liver membranes in long-lived rats fed on a coenzyme Q10-supplemented diet. Exp. Gerontol. 2005, 40, 694-706.
22. Kamzalov, S., Sohal, R. S., Effect of age and caloric restriction on coenzyme Q and alpha-tocopherol levels in the rat. Exp. Gerontol. 2004, 39, 1199-1205.
23. Valls, V., Castelluccio, C., Fato, R., Genova, M. L. et al., Protective effect of exogenous coenzyme Q against damage by adriamycin in perfused rat liver. Biochem. Mol. Biol. Int. 1994, 33, 633-642.
24. Beyer, R. E., Segura-Aguilar, J., Di Bernardo, S., Cavazzoni, M. et al., The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc. Natl. Acad. Sci. USA 1996, 93, 2528-2532.
25. Kalen, A., Appelkvist, E. L., Dallner, G., Age-related changes in the lipid compositions of rat and human tissues. Lipids 1989, 24, 579-584.
26. Farooqui, T., Farooqui, A. A., Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mech. Ageing Dev. 2009, 130, 203-215.
27. Fusco, D., Colloca, G., Lo Monaco, M. R., Cesari, M., Effects of antioxidant supplementation on the aging process. Clin. Interv. Aging 2007, 2, 377-387.
28. Littarru, G. P., Langsjoen, P., Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion 2007, 7, S168-S174.
29. Kunitomo, M., Yamaguchi, Y., Kagota, S., Otsubo, K., Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual meta-bolic components developing in a rat model of metabolic syndrome. J. Pharmacol. Sci. 2008, 107, 128-137.
30. Lankin, V. Z., Tikhaze, A. K., Kapel'ko, V. I., Shepel'kova, G. S. et al., Mechanisms of oxidative modification of low density lipoproteins under conditions of oxidative and carbonyl stress. Biochemistry (Mosc) 2007, 72, 1081-1090.
31. Kaliora, A. C., Dedoussis, G. V., Schmidt, H., Dietary anti-oxidants in preventing atherogenesis. Atherosclerosis 2006, 187, 1-17.
32. Lankin, V. Z., Tikhaze, A. K., Kukharchuk, V. V., Konovalova, G. G. et al., Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins. Mol. Cell Biochem. 2003, 249, 129-140.
33. Thomas, S. R., Leichtweis, S. B., Pettersson, K., Croft, K. D. et al., Dietary cosupplementation with vitamin E and coen-zyme Q(10) inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 585-593.
34. Kaikkonen, J., Tuomainen, T. P., Nyyssonen, K., Salonen, J. T., Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels. Free. Radic. Res. 2002, 36, 389-397.
35. Thomas, S. R., Neuzil, J., Stocker, R., Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Arterioscler. Thromb. Vasc. Biol. 1996, 16, 687-696.
36. Schoonjans, K., Staels, B., Auwerx, J., Role of the peroxi-some proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 1996, 37, 907-925.
37. Ide, T., Shimano, H., Yoshikawa, T., Yahagi, N. et al., Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol. Endocrinol. 2003, 17, 1255-1267.
38. Costet, P., Legendre, C., More, J., Edgar, A. et al., Peroxi-some proliferator-activated receptor alpha-isoform defi-ciency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. J. Biol. Chem. 1998, 273, 29577-29585.
39. Konig, B., Koch, A., Spielmann, J., Hilgenfeld, C. et al., Activation of PPARalpha lowers synthesis and concentra-tion of cholesterol by reduction of nuclear SREBP-2. Biochem. Pharmacol. 2007, 73, 574-585.
40. Cook, W. S., Yeldandi, A. V., Rao, M. S., Hashimoto, T., Reddy, J. K., Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha. Biochem. Biophys. Res. Commun. 2000, 278, 250-257.
41. Cuzzocrea, S., Mazzon, E., Di Paola, R., Peli, A. et al., The role of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in the regulation of acute inflammation. J. Leukoc. Biol. 2006, 79, 999-1010.
42. Delayre-Orthez, C., Becker, J., Guenon, I., Lagente, V. et al., PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respir. Res. 2005, 6, 91.
43. Zambon, A., Gervois, P., Pauletto, P., Fruchart, J. C., Staels, B., Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clin-ical and experimental evidence. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 977-986.
44. Chinetti, G., Fruchart, J. C., Staels, B., Peroxisome prolif-erator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 2000, 49, 497-505.
45. Lee, J. H., Joe, E. H., Jou, I., PPAR-alpha activators suppress STAT1 inflammatory signaling in lipopolysaccharide-acti-vated rat glia. Neuroreport 2005, 16, 829-833.
46. Gervois, P., Torra, I. P., Fruchart, J. C., Staels, B., Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin. Chem. Lab. Med. 2000, 38, 3-11.
47. Cummins, C. L., Mangelsdorf, D. J., Liver X receptors and cholesterol homoeostasis: spotlight on the adrenal gland. Biochem. Soc. Trans. 2006, 34, 1110-1113.
48. Repa, J. J., Liang, G., Ou, J., Bashmakov, Y. et al., Regula-tion of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 2000, 14, 2819-2830.
49. Hua, X., Wu, J., Goldstein, J. L., Brown, M. S., Hobbs, H. H., Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics 1995, 25, 667-673.
50. Horton, J. D., Goldstein, J. L., Brown, M. S., SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109, 1125-1131.
51. Shimomura, I., Shimano, H., Korn, B. S., Bashmakov, Y., Horton, J. D., Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J. Biol. Chem. 1998, 273, 35299-35306.
52. Osborne, T. F., Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 2000, 275, 32379-32382.
53. Carmona, M. C., Lefebvre, P., Lefebvre, B., Galinier, A. et al., Coadministration of CoQ prevents Rosiglitazone-induced adipogenesis in ob/ob mice. Int. J. Obes. 2009, 33, 204-211.
54. Gelinas, D. S., McLaurin, J., PPAR-alpha expression inver-sely correlates with inflammatory cytokines IL-1beta and TNF-alpha in aging rats. Neurochem. Res. 2005, 30, 1369-1375.